DMG BLOCKCHAIN SOLUTIONS INC
DMGGF
BTCS Inc
BTCS
Bit Digital
BTBT
NEPTUNE DIGITAL ASSETS CORP
NPPTF
TeraWulf
WULF
US Stock MarketDetailed Quotes
MYNZ Mainz Biomed
- 7.320
- +0.400+5.78%
Close Dec 4 16:00 ET
- 7.320
- 0.0000.00%
Post 16:24 ET
14.66MMarket Cap-164P/E (TTM)
7.400High6.500Low154.29KVolume6.980Open6.920Pre Close1.07MTurnover10.19%Turnover RatioLossP/E (Static)2.00MShares53.60052wk High-3.54P/B11.08MFloat Cap6.20152wk Low--Dividend TTM1.51MShs Float1200.000Historical High--Div YieldTTM13.01%Amplitude6.201Historical Low6.956Avg Price1Lot Size
Mainz Biomed News
Mainz Biomed | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Mainz Biomed | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Mainz Biomed | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Mainz Biomed | F-1: Registration statement for securities of certain foreign private issuers
Mainz Biomed | 6-K: Report of foreign private issuer (related to financial reporting)
Mainz Biomed | 6-K: Report of foreign private issuer (related to financial reporting)
Mainz Biomed | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Mainz Biomed | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-KfW(4.4%)
Mainz Biomed | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Mainz Biomed | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Mainz Biomed | D/A: Filing D (Amendment)
Mainz Biomed | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Mainz Biomed | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Mainz Biomed | 20-F: FY2023 Annual Report
Mainz Biomed | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Mainz Biomed | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-KfW(6.4%)
Mainz Biomed | 6-K: Report of foreign private issuer (related to financial reporting)
Mainz Biomed | 6-K: Report of foreign private issuer (related to financial reporting)
Mainz Biomed | 424B5: Prospectus
Mainz Biomed | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]